BUZZ-Indian pharma shares extend losses on US tariffs; brokerages see limited impact

Reuters04-06

BUZZ-Indian pharma shares extend losses on US tariffs; brokerages see limited impact

** Indian pharmaceutical stocks .NIPHARM down ~1.4%, extending fall for fifth straight session; all 20 constituents in the red

** U.S. President Donald Trump signed executive order on Thursday imposing 100% tariffs on branded pharmaceuticals imported into the U.S.

** U.S. is India's largest market for pharmaceutical exports, accounting for over a third of the total volume, mostly of cheaper generic drugs

** J.P. Morgan estimates the impact on Indian generic makers to be limited, citing exemptions and preferential tariff rates tied to trade‑deal regions

** Contract development and manufacturing organisation risks are also seen contained, as tariff costs are typically borne by clients, J.P. Morgan says

** Brokerage sees the order "largely benign" for Indian pharma; names Torrent TORP.NS, Sun Pharma SUN.NS, Lupin LUPN.NS and Mankind Pharma MNKI.NS as its top picks

** Jefferies says among pharma names only Sun Pharma's specialty segment could be impacted by the tariffs; the impact can be completely mitigated using transfer pricing or price hikes

(Reporting by Brijesh Patel in Bengaluru)

((Brijesh.Patel1@thomsonreuters.com; Ph no. +91 9590227221;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2625210624?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-06 12:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2625210624","market":"us","top_or_hot":-1,"title":"BUZZ-Indian pharma shares extend losses on US tariffs; brokerages see limited impact","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Indian pharma shares extend losses on US tariffs; brokerages see limited impact</title></head><body><p>** Indian pharmaceutical stocks <span>.NIPHARM</span> down ~1.4%, extending fall for fifth straight session; all 20 constituents in the red </p><p>** U.S. President Donald Trump <span>signed</span> executive order on Thursday imposing 100% tariffs on branded pharmaceuticals imported into the U.S.</p><p>** U.S. is India's largest market for pharmaceutical exports, accounting for over a third of the total volume, mostly of cheaper generic drugs</p><p>** J.P. Morgan estimates the impact on Indian generic makers to be limited, citing exemptions and preferential tariff rates tied to trade‑deal regions</p><p>** Contract development and manufacturing organisation risks are also seen contained, as tariff costs are typically borne by clients, J.P. Morgan says</p><p>** Brokerage sees the order \"largely benign\" for Indian pharma; names Torrent <span>TORP.NS</span>, Sun Pharma <span>SUN.NS</span>, Lupin <span>LUPN.NS</span> and Mankind Pharma <span>MNKI.NS</span> as its top picks </p><p>** Jefferies says among pharma names only Sun Pharma's specialty segment could be impacted by the tariffs; the impact can be completely mitigated using transfer pricing or price hikes</p><p> (Reporting by Brijesh Patel in Bengaluru)</p><p> ((Brijesh.Patel1@thomsonreuters.com; Ph no. +91 9590227221;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Indian pharma shares extend losses on US tariffs; brokerages see limited impact</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Indian pharma shares extend losses on US tariffs; brokerages see limited impact\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-04-06 12:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Indian pharma shares extend losses on US tariffs; brokerages see limited impact</title></head><body><p>** Indian pharmaceutical stocks <span>.NIPHARM</span> down ~1.4%, extending fall for fifth straight session; all 20 constituents in the red </p><p>** U.S. President Donald Trump <span>signed</span> executive order on Thursday imposing 100% tariffs on branded pharmaceuticals imported into the U.S.</p><p>** U.S. is India's largest market for pharmaceutical exports, accounting for over a third of the total volume, mostly of cheaper generic drugs</p><p>** J.P. Morgan estimates the impact on Indian generic makers to be limited, citing exemptions and preferential tariff rates tied to trade‑deal regions</p><p>** Contract development and manufacturing organisation risks are also seen contained, as tariff costs are typically borne by clients, J.P. Morgan says</p><p>** Brokerage sees the order \"largely benign\" for Indian pharma; names Torrent <span>TORP.NS</span>, Sun Pharma <span>SUN.NS</span>, Lupin <span>LUPN.NS</span> and Mankind Pharma <span>MNKI.NS</span> as its top picks </p><p>** Jefferies says among pharma names only Sun Pharma's specialty segment could be impacted by the tariffs; the impact can be completely mitigated using transfer pricing or price hikes</p><p> (Reporting by Brijesh Patel in Bengaluru)</p><p> ((Brijesh.Patel1@thomsonreuters.com; Ph no. +91 9590227221;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0046","symbol_name":"生物疫苗","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nL4N40P06K:1","article_id":"2625210624","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2625210624","pubTimestamp":1775451537,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Indian pharma shares extend losses on US tariffs; brokerages see limited impact** Indian pharmaceutical stocks .NIPHARM down ~1.4%, extending fall for fifth straight session; all 20 constituents in the red ** U.S. President Donald Trump signed executive order on Thursday imposing 100% tariffs on branded pharmaceuticals imported into the U.S.** U.S. is India's largest market for pharmaceutical exports, accounting for over a third of the total volume, mostly of cheaper generic drugs** J.P. Morgan estimates the impact on Indian generic makers to be limited, citing exemptions and preferential tariff rates tied to tradedeal regions** Contract development and manufacturing organisation risks are also seen contained, as tariff costs are typically borne by clients, J.P. Morgan says** Brokerage sees the order \"largely benign\" for Indian pharma; names Torrent TORP.NS, Sun Pharma SUN.NS, Lupin LUPN.NS and Mankind Pharma MNKI.NS as its top picks ** Jefferies says among pharma names only Sun P","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300485":"赛升药业","BK0046":"生物疫苗","BK0239":"医药制造","BK0012":"证金概念","BK0028":"国家队"},"translate_title":"嗡嗡声——印度制药股因美国关税而扩大跌幅；券商认为影响有限","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300485":0.9},"content_text":"BUZZ-Indian pharma shares extend losses on US tariffs; brokerages see limited impact** Indian pharmaceutical stocks .NIPHARM down ~1.4%, extending fall for fifth straight session; all 20 constituents in the red ** U.S. President Donald Trump signed executive order on Thursday imposing 100% tariffs on branded pharmaceuticals imported into the U.S.** U.S. is India's largest market for pharmaceutical exports, accounting for over a third of the total volume, mostly of cheaper generic drugs** J.P. Morgan estimates the impact on Indian generic makers to be limited, citing exemptions and preferential tariff rates tied to trade‑deal regions** Contract development and manufacturing organisation risks are also seen contained, as tariff costs are typically borne by clients, J.P. Morgan says** Brokerage sees the order \"largely benign\" for Indian pharma; names Torrent TORP.NS, Sun Pharma SUN.NS, Lupin LUPN.NS and Mankind Pharma MNKI.NS as its top picks ** Jefferies says among pharma names only Sun Pharma's specialty segment could be impacted by the tariffs; the impact can be completely mitigated using transfer pricing or price hikes (Reporting by Brijesh Patel in Bengaluru) ((Brijesh.Patel1@thomsonreuters.com; Ph no. +91 9590227221;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2625210624","isCrawlerRequest":true}